HIGHFDA DRUG

Amneal 800mg/160mg Sulfamethoxazole and Trimethoprim Tablets Recalled for Foreign Packaging Material

Amneal Pharmaceuticals recalled 60,072 100-count bottles and 73,054 500-count bottles of sulfamethoxazole and trimethoprim tablets. A foreign packaging material was detected in a lot, with no tablets contaminated. The recall is nationwide and ongoing as of the report date.

Official notice

Source-backed recall notice

No product image was available from the source feed.

Official source
FDA DRUG
Recall date
August 18, 2025
Status
ACTIVE
Severity
8/10

Quick Facts at a Glance

Recall Date
August 18, 2025
Hazard Level
HIGH
Brands
SULFAMETHOXAZOLE AND TRIMETHOPRIM, Amneal Pharmaceuticals LLC
Category
Health & Personal Care
Sold At
Unknown
Geographic Scope
1 states
At-Risk Groups
GENERAL

What to Do Now

Use this page like a recall checklist: verify the product first, then act on the official remedy.

Immediate steps

  1. 1Stop using the product until you confirm whether it is included in the recall.
  2. 2Compare the product label, model number, UPC, color, size, and purchase location against the identifiers below.
  3. 3Follow the official remedy from FDA - Drug Safety; save photos, receipts, labels, and correspondence before contacting the company.
  4. 4If the product could harm a child, older adult, pet, or patient, move it out of reach immediately.

Check these identifiers

Brand
SULFAMETHOXAZOLE AND TRIMETHOPRIM, Amneal Pharmaceuticals LLC
Product type
Antibiotic Tablets
Model numbers
AM240173, AM240176, AM240177, AM240301, AM240300, AM240676, AM240677, AM240678 +5 more
UPC codes
65162-271, 65162-272, 65162-271-05, 65162-271-10, 65162-271-50, 65162-271-11, 65162-272-01, 65162-272-24 +3 more
Sold at
Unknown
Where affected
ALL

Recall Timeline

Key dates and source checks for this recall record.

  1. Recall announced

    August 18, 2025

  2. Reported by FDA DRUG

    September 10, 2025

  3. RecallRadar source check

    April 18, 2026

  4. Consumer action

    Use the official remedy and keep documentation.

Hazard Information

Presence of a foreign substance.A specific lot of auxiliary polyester coil, used in product packaging was detected with presence of a micro-organism. No micro-organism was detected on any tablets.

What You Should Do

Consumers and healthcare providers should stop using this product immediately. Contact Amneal Pharmaceuticals, LLC or your healthcare provider for guidance. Notification method: Letter

About This Product

This antibiotic is used to treat bacterial infections. The double-strength tablet is prescribed for specific infections and dosages per clinician instruction.

Why This Is Dangerous

A foreign packaging material fragment could contaminate the product packaging. Although no tablets were found contaminated, the potential risk warrants withdrawal from distribution.

Industry Context

This recall is not described as part of a broader pattern in the provided data.

Real-World Impact

Consumers may face interruption of antibiotic therapy and potential need for replacement at healthcare provider's guidance.

Practical Guidance

How to identify if yours is affected

  1. Confirm packaging is from Amneal Pharmaceuticals

Where to find product info

Label on bottle shows NDC and lot number. FDA recall notice provides lot and bottle size details.

What timeline to expect

Refunds or replacements will be arranged after recall notification by mail. Expect several weeks to process.

If the manufacturer is unresponsive

  • File a consumer complaint with the FDA
  • Consult healthcare provider for safe alternative therapy

How to prevent similar issues

  • Always verify NDC and lot numbers before consuming any medication
  • Prefer purchases from reputable pharmacies with clear recall notices
  • Register prescription medications at the manufacturer’s portal if available

Documentation advice

Save recall notice, take photographs of the bottle label, and keep all correspondence with the pharmacy and manufacturer

Get instant alerts for Health & Personal Care recalls

Be the first to know. Free instant alerts to your inbox.

No spamUnsubscribe anytime

Product Details

Product: Sulfamethoxazole and Trimethoprim Tablets, USP 800mg/160mg Double Strength. Packaging: 100-count bottle (NDC 65162-272-10) and 500-count bottle (NDC 65162-272-50). Manufacturer: Amneal Pharmaceuticals Pvt. Ltd, Ahmedabad, India. Distributor: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807. Lots involved: AM240173, AM240176, AM240177, AM240301, AM240300, AM240676, AM240677, AM240678, AM240679, AM240680, AM240921, AM240922, AM240923. Quantity recalled: 60,072 (100-count) and 73,054 (500-count). Distribution: Nationwide in the USA. Recall date: 2025-08-18. Report date: 2025-09-10.

Reported Incidents

No injuries or incidents have been reported.

Key Facts

  • 60,072 100-count bottles recalled
  • 73,054 500-count bottles recalled
  • AM240680, AM240921, AM240922, AM240923
  • Packaging polyester coil associated with micro-organism detected

Safety Guide

Not sure what to do next? Our guide walks you through the process step by step.

Read: What to Do When You Find a Recalled Product

Get Alerts for Health & Personal Care Recalls

Get instant alerts for recalls that affect you. Free forever.

Safety Assessment

Risk LevelHIGH
Severity Score
8/ 10
Affected Groups
GENERAL
Injury Types
POISONINGOTHER

Product Details

Model Numbers
AM240173
AM240176
AM240177
AM240301
AM240300
+8 more
UPC Codes
65162-271
65162-272
65162-271-05
+8 more
Affected States
ALL
Report Date
September 10, 2025
Source Agency
FDA - Drug Safety
Recall Status
ACTIVE

Related Recalls

Health & Personal Care
MEDIUM

AvKARE Recalls Rosuvastatin Tablets Due to Dissolution Issues

AvKARE recalled 7,991 cartons of Rosuvastatin Tablets on December 31, 2025. The recall stems from the product being out of specification for dissolution. Consumers should stop using the medication immediately and consult healthcare providers for guidance.

SUN PHARMACEUTICAL INDUSTRIES
Labeling: Not
Read more